Cirqle Biomedical Holding ApS: Financial statements 2022
CVR: 39849585
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Cirqle Biomedical Holding ApS (CVR 39849585) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -9,761 and a net result of DKK -4,590 compared with DKK -11,725 the year before. Equity in the 2022 report amounted to DKK 20,906. The solvency ratio was 0.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -9,761
- Profit/Loss
- DKK -4,590
- Equity
- DKK 20,906
- Total Assets
- DKK 12,231,060
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -10K | -5K | 21K | 1 |
| 2021 | - | -7K | -12K | 25K | 1 |
| 2020 | - | -7K | -10K | 37K | 1 |
Official annual report
Keep an eye on Cirqle Biomedical Holding ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Cirqle Biomedical Holding ApS has published its annual report for 2021. Gross profit came to DKK -6,729, and the net result was DKK -11,725.
About Cirqle Biomedical Holding ApS
Cirqle Biomedical Holding ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Circle Biomedical Holding ApS and Circle Biomedical Holding IVS. The management consists of Frederik Petursson Madsen and Thomas Crouzier. The company is owned by FREDERIK MADSEN HOLDING ApS and Seatoo Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -60,937 and a net result of DKK -137,510 compared with DKK 12,948,727 the year before. Equity in the 2025 report amounted to DKK 577,835.